BioSpace News Archive

IsoPlexis announced today that it has received $1.8M in grant funding from the NCI’s Small Business Innovation Research (NCI SBIR) Development Center to develop an automated assay platform and informatics suite that can be used in larger clinical trials to test CAR-T patient product potency and toxicity, pre-infusion, in order to help predict patient response and inform usage of these therapies.

The National Psoriasis Foundation announces that the PCORI Board of Governors has approved $8.6M in funding for a new study comparing psoriasis phototherapy treatment options.

CytoSen Therapeutics announced today the appointment of Jak Knowles, M.D. as CEO and five new members to the company’s scientific and medical advisory board.

OncoSec announced today that it has entered into definitive purchase agreements with certain accredited investors to purchase 5,270,934 shares of its common stock, at a purchase price per share of $1.34375 in a registered direct offering priced at the market.

Boehringer Ingelheim announced today the presentation of a new analysis on the use of Ofev (nintedanib) in treating people with idiopathic pulmonary fibrosis (IPF) at the 2017 CHEST Annual Meeting.

Today, Sun Pharma launched ABSORICA Tracker App to help patients get the most out of their treatment.

AMPAC Fine Chemicals is pleased to announce that Don Whiteaker has been promoted to the position of VP, Supply Chain and Dr. Jeff Butler has been promoted to the position of Executive Director, Project Management.

Dynatronics today announced that it has signed an exclusive distribution agreement for the United States with Zimmer for select therapy equipment.

EMD Serono today announced the appointment of Robert Truckenmiller as Senior VP, Market Access & Customer Solutions.

Science Exchange, a platform for outsourced research and development (R&D) services, today announced a partnership with QB3, the University of California hub for innovation and entrepreneurship for life sciences.